|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: KERYX BIOPHARMACEUTICALS INC, 10-Q, EX-3.1, 2000-09-11 |
Next: FIRSTMARK COMMUNICATIONS EUROPE SA, S-1/A, 2000-09-11 |
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<CURRENCY>
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 3-MOS
<FISCAL-YEAR-END> DEC-31-1999 DEC-31-1999
<PERIOD-START> JAN-01-1999 MAR-01-2000
<PERIOD-END> DEC-31-1999 JUN-30-2000
<EXCHANGE-RATE> 0 0
<CASH> 4,126,735 5,033,424
<SECURITIES> 0 0
<RECEIVABLES> 166,137 89,122
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 4,378,557 5,240,621
<PP&E> 160,141 176,819
<DEPRECIATION> 0 0
<TOTAL-ASSETS> 4,948,216 6,835,807
<CURRENT-LIABILITIES> 394,417 741,278
<BONDS> 0 0
0 0
79 118
<COMMON> 1,208 8,108
<OTHER-SE> 4,436,063 5,935,426
<TOTAL-LIABILITY-AND-EQUITY> 4,948,216 6,835,807
<SALES> 0 0
<TOTAL-REVENUES> 0 0
<CGS> 0 0
<TOTAL-COSTS> 8,735,305 3,303,874
<OTHER-EXPENSES> 257,487 (97,947)
<LOSS-PROVISION> 8,992,742 0
<INTEREST-EXPENSE> 0 0
<INCOME-PRETAX> 0 (3,205,927)
<INCOME-TAX> 9,970 27,879
<INCOME-CONTINUING> (9,002,762) (3,233,806)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (9,002,762) (3,233,806)
<EPS-BASIC> (1.11) (0.40)
<EPS-DILUTED> (1.11) (0.40)
</TABLE>
|
|